Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 2/20 | 0.38 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6908029 | 0.78 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL5689799 | 0.78 | CA1 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL50148 | 0.77 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29405044 | 0.77 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10414766 | 0.77 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8419557 | 0.75 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL7972166 | 0.75 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3410866 | 0.75 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| SCHEMBL15658840 | 0.75 | CA1 (0.57) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17529710 | 0.75 | CA1 (0.57) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2847149-B1 | OLIGOMERISATION OF OLEFINIC COMPOUNDS WITH REDUCED POLYMER FORMATION | SASOL TECH PTY LTD (ZA) | 2022-01-12 | — | — | EP | disclosed |
| US-10407358-B2 | Process for ethylene oligomerization to produce alpha-olefins | SAUDI ARABIAN OIL COMPANY (SA) | 2019-09-10 | — | — | US | disclosed |
| US-9447202-B2 | Oligomerisation of olefinic compounds with reduced polymer formation | SASOL TECHNOLOGY (PROPRIETARY) LIMITED (ZA) | 2016-09-20 | — | — | US | disclosed |
| US-9073810-B2 | Catalyst systems for the catalytic oligomerization of olefinic monomers | SHELL OIL COMPANY (US) | 2015-07-07 | — | — | US | disclosed |
| US-9073810-B2 | Catalyst systems for the catalytic oligomerization of olefinic monomers | SHELL OIL COMPANY (US) | 2015-07-07 | — | — | US | disclosed |
| US-9073809-B2 | Catalyst systems for the catalytic oligomerization of olefinic monomers | SHELL OIL COMPANY (US) | 2015-07-07 | — | — | US | disclosed |
| US-9073809-B2 | Catalyst systems for the catalytic oligomerization of olefinic monomers | SHELL OIL COMPANY (US) | 2015-07-07 | — | — | US | disclosed |
| US-20150152200-A1 | Oligomerisation of Olefinic Compounds with Reduced Polymer Formation | SASOL TECHNOLOGY (PROPRIETARY) LIMITED (ZA) | 2015-06-04 | — | — | US | disclosed |
| US-20140135551-A1 | Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers | SHELL OIL COMPANY (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140135551-A1 | Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers | SHELL OIL COMPANY (US) | 2014-05-15 | — | — | US | disclosed |
| US-20100311929-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | DE BOER ERIC JOHANNES MARIA | 2010-12-09 | — | — | US | disclosed |
| US-20100311932-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | DE BOER ERIC JOHANNES MARIA | 2010-12-09 | — | — | US | disclosed |
| US-20100311932-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | DE BOER ERIC JOHANNES MARIA | 2010-12-09 | — | — | US | disclosed |
| US-20100311929-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | DE BOER ERIC JOHANNES MARIA | 2010-12-09 | — | — | US | disclosed |
| US-20100311928-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | DE BOER ERIC JOHANNES MARIA | 2010-12-09 | — | — | US | disclosed |
| US-20100311928-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | DE BOER ERIC JOHANNES MARIA | 2010-12-09 | — | — | US | disclosed |
| US-7803886-B2 | Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers | SHELL OIL COMPANY (US) | 2010-09-28 | — | — | US | disclosed |
| US-7803886-B2 | Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers | SHELL OIL COMPANY (US) | 2010-09-28 | — | — | US | disclosed |
| US-20090062493-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | SHELL OIL COMPANY | 2009-03-05 | — | — | US | disclosed |
| US-20090062493-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | SHELL OIL COMPANY | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062493-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | MSMO1, BPHL, CCNL2 | CA1 1630/4885CA2 813/4885CA7 2389/4885 |
| US-10407358-B2 | Process for ethylene oligomerization to produce alpha-olefins | EEF1D, ECH1, ERO1A | CA1 3796/4885CA2 4139/4885CA7 2898/4885 |
| US-20100311928-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | OXER1, NOD2, OPRM1 | CA1 3782/4885CA2 3798/4885CA7 4208/4885 |
| US-20140135551-A1 | Catalyst Systems for the Catalytic Oligomerization of Olefinic Monomers | CCNL2, POR, INTS9 | CA1 2227/4885CA2 1391/4885CA7 2213/4885 |
| US-20100311929-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | COG4, OXER1, RRS1 | CA1 4181/4885CA2 4484/4885CA7 4380/4885 |
| US-20100311932-A1 | LIGANDS AND CATALYST SYSTEMS THEREOF FOR THE CATALYTIC OLIGOMERIZATION OF OLEFINIC MONOMERS | CDK20, INTS9, CCNL2 | CA1 2626/4885CA2 1917/4885CA7 2532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.